MSSTFOTCHealthcare · Biotechnology

Mindset Pharma Inc.

$0.54-0.37%($-0.00)

TickerSpark Score

60/100

Mixed

Valuation

Profitability

Growth

Health

100

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MSSTF research report →

52-Week Range95% of range

Low $0.16

Current $0.54

High $0.56

Companywww.mindsetpharma.com

Mindset Pharma Inc. develops and sells psychedelic medicines to treat neurological and psychiatric disorders in Canada. It focuses on developing MSP-1014, a psychedelic drug candidate.

CEO: James Andre-Charles Lanthier
IPO: 2021
HQ: Toronto, ON, CA

Price Chart

+70.44% · this period

Valuation

Market Cap: $54.51M
P/E: -4.01
P/S: 19.19
P/B: 44.81
EV/EBITDA: -4.02
Div Yield: 0.00%

Profitability

Gross Margin: 100.00%
Op Margin: -424.40%
Net Margin: -425.24%
ROE: -316.17%
ROIC: -999.11%

Growth & Income

Revenue: $3.91M · 0.00%
Net Income: $-16,610,000 · -42.54%
EPS: $-0.18 · 10.00%
Op Income: $-16,577,000
FCF YoY: 104.61%

Performance & Tape

52W High: $0.56
52W Low: $0.16
50D MA: $0.52
200D MA: $0.32
Beta: -0.10
Avg Volume: 57.61K

Get TickerSpark's AI analysis on MSSTF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime